Target Price | $6.00 |
Price | $1.08 |
Potential |
455.56%
register free of charge
|
Number of Estimates | 2 |
2 Analysts have issued a price target Iterum Therapeutics Plc 2025 .
The average Iterum Therapeutics Plc target price is $6.00.
This is
455.56%
register free of charge
$7.00
548.15%
register free of charge
$5.00
362.96%
register free of charge
|
|
A rating was issued by 2 analysts: 2 Analysts recommend Iterum Therapeutics Plc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Iterum Therapeutics Plc stock has an average upside potential 2025 of
455.56%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -2.96 | -1.11 |
18.46% | 62.50% | |
P/E | negative |
2 Analysts have issued a Iterum Therapeutics Plc forecast for earnings per share. The average Iterum Therapeutics Plc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Iterum Therapeutics Plc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.